Further in vivo animal studies revealed TVB-2640 sensitized chemotherapy-resistant tumor cells to etoposide treatment and inhibited USP13-dependent cancer stemness and tumor growth, suggesting a crucial role of lipogenic pathway in SCLC proliferation and drug resistance. This evidence concerns the gene USP13 and cancer.